NYSEArca - Nasdaq Real Time Price USD

SPDR S&P Pharmaceuticals ETF (XPH)

38.99 -0.51 (-1.29%)
As of 11:13 AM EDT. Market Open.
Loading Chart for XPH
DELL
  • Previous Close 39.50
  • Open 39.25
  • Bid 39.00 x 1100
  • Ask 39.01 x 3000
  • Day's Range 38.94 - 39.22
  • 52 Week Range 34.67 - 45.62
  • Volume 8,379
  • Avg. Volume 37,127
  • Net Assets 219.96M
  • NAV 39.52
  • PE Ratio (TTM) 14.04
  • Yield 1.37%
  • YTD Daily Total Return -4.70%
  • Beta (5Y Monthly) 0.66
  • Expense Ratio (net) 0.35%

In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

SPDR State Street Global Advisors

Fund Family

Health

Fund Category

219.96M

Net Assets

2006-06-19

Inception Date

Performance Overview: XPH

Trailing returns as of 4/24/2024. Category is Health.

YTD Return

XPH
4.70%
Category
6.33%
 

1-Year Return

XPH
5.39%
Category
11.04%
 

3-Year Return

XPH
5.84%
Category
0.38%
 

People Also Watch

Holdings: XPH

Top 10 Holdings (46.53% of Total Assets)

SymbolCompany% Assets
AXSM
Axsome Therapeutics, Inc. 4.87%
MRK
Merck & Co., Inc. 4.82%
PRGO
Perrigo Company plc 4.73%
ITCI
Intra-Cellular Therapies, Inc. 4.63%
JAZZ
Jazz Pharmaceuticals plc 4.62%
LLY
Eli Lilly and Company 4.61%
PFE
Pfizer Inc. 4.60%
OGN
Organon & Co. 4.60%
BMY
Bristol-Myers Squibb Company 4.55%
RPRX
Royalty Pharma plc 4.51%

Sector Weightings

SectorXPH
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related ETF News

Research Reports: XPH

  • JOE: Raising target price to $60.00

    ST JOE CO/THE has an Investment Rating of HOLD; a target price of $60.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • RMBS: Lowering target price to $59.00

    RAMBUS INC has an Investment Rating of HOLD; a target price of $59.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • Analyst Report: ASML Holding N.V.

    ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s main clients are TSMC, Samsung, and Intel.

    Rating
    Price Target
     
  • VRSN: Raising target price to $201.00

    VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

Related Tickers